Psilocybin-Research.comSearchable psilocybin and psilocin bibliometrics.
Published

2,5-dimethoxy-4-methyl-amphetamine (STP): a new hallucinogenic drug.

We have assessed the effects in normal control volunteers of 2,5-dimethoxy-4-methyl-amphetamine, the chemical present in the hallucinogenic drug STP, in two independent trials. In low doses, this compound produces a mild euphoria. Doses greater than 3 milligrams may cause pronounced hallucinogenic effects lasting about 8 hours and similar to those produced by hallucinogenic doses of lysergic acid diethylamide, mescaline, and psilocybin. 2,5-Dimethoxy-4-methyl-amphetamine, which is chemically related to mescaline and amphetamine, is about 100 times more potent as a hallucinogen than mescaline and only one-thirtieth as potent as lysergic acid diethylamide. Its psychological effects are not accentuated by chlorpromazine.

Open source BibTeX RIS

Bibliographic context

Journal
Unknown
Date
1967-10-31
Source
Europe PMC
DOI
10.1126/science.158.3801.669
PubMed
4860952

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

No close related records were found yet.